For example, in 75 patients starting anti-TNF therapy for rheumatoid arthritis or spondyloarthropathies, three patients who developed neurological symptoms demonstrated new cortical lesions consistent with demyelination on MRI6. The gene discussed is TNF; the disease is Peripheral demyelination.